Immediate Impact
33 from Science/Nature 62 standout
Citing Papers
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
2023 StandoutNature
Works of Gregory N. Dietsch being referenced
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN
2016
A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gregory N. Dietsch | 764 | 418 | 95 | 247 | 24 | 1.4k | |
| Alvin W. Martin | 436 | 527 | 77 | 311 | 44 | 1.5k | |
| Dana Thomasová | 479 | 148 | 56 | 663 | 23 | 1.4k | |
| Laura Quigley | 868 | 220 | 64 | 244 | 31 | 1.4k | |
| Konrad Buscher | 740 | 130 | 173 | 457 | 26 | 1.4k | |
| Cynthia Webb | 489 | 488 | 24 | 633 | 34 | 1.6k | |
| Zdenka Jonak | 572 | 361 | 103 | 540 | 37 | 1.4k | |
| Xiaobo Wu | 836 | 122 | 109 | 226 | 34 | 1.4k | |
| Lu Lu | 777 | 232 | 36 | 467 | 21 | 1.2k | |
| Patricia A. Nelson | 672 | 126 | 41 | 306 | 27 | 1.3k | |
| Elizabeth G. Lingenheld | 1191 | 226 | 126 | 235 | 25 | 1.6k |
All Works
Loading papers...